Carson Michael J.
SEC CIK 1896079 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma, Inc. | VP, Fin | 230.1K | — | $22.5K | 5 | 2023-01-03 | 2026-08-03 |
Most active insiders at NVCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mosseri Marlio Charles | 10% | $1.87M | — |
| 2 | BENTSUR RON | COB, CEO, Dir, 10% | $278.6K | — |
| 3 | Sanchez Juan | Dir | $75.3K | — |
| 4 | Kaplan Matthew L. | Dir | $64.2K | — |
| 5 | Poradosu Enrique | Chief Science, Business Off | — | — |
| 6 | Carson Michael J. | VP, Fin | — | — |
| 7 | Shemesh Shay | Chief Dev, Ops. Off | — | — |
| 8 | Hoberman Kenneth | Dir | — | — |
| 9 | Oliviero James F III | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 17:26 | 2026-08-03 | NVCT | Nuvectis Pharma, Inc. | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +30.0K | 230.1K | +15% | $0 | |
| 2026-01-09 | 2026-01-06 | NVCT | Nuvectis Pharma, Inc. | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +61.2K | 200.1K | +44% | $0 | |
| 2025-01-03 | 2025-01-02 | NVCT | Nuvectis Pharma, Inc. | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +51.0K | 138.9K | +58% | $0 | |
| 2024-11-08 | 2024-11-07 | NVCT | Nuvectis Pharma, Inc. | Carson Michael J. | VP, Fin | S - Sale | $8.16 | -2,755 | 87.9K | -3% | -$22.5K | |
| M | 2024-11-08 | 2023-01-03+ | NVCT | Nuvectis Pharma, Inc. | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +63.4K | 90.7K | +232% | $0 |
Purchase Sale Sale after option exercise All abbreviations